Paediatrics · MOHFW

Childhood pneumonia and respiratory infection

MOHFW

Source:MoHFW Standard Treatment Guidelines — Respiratory Infections in Children (2021)IMCI/IMNCI (2021)WHO Pocket Book of Hospital Care for Children (2021)

Verified Apr 2026

Ask House about this guideline

Red Flags

Severe respiratory distress (severe chest indrawing, head bobbing, grunting, central cyanosis, SpO2 <90%) — admit, oxygen, antibiotic^[1]
Inability to feed or drink, persistent vomiting, lethargy, convulsions in young infant — possible serious bacterial infection (PSBI); pre-referral antibiotics + urgent transfer^[1]
Children <2 months with fast breathing (>60/min), fever or hypothermia, or any danger sign — admit; do not manage as ambulatory ARI^[1]
Failure to respond to first-line antibiotic at 48 hours — switch antibiotic, investigate for empyema/abscess, escalate care^[1]

First-line treatment

Interventions

Distinguish viral ARI from bacterial pneumonia^[1]
Most ARIs in children are viral and self-limiting — runny nose, cough without fast breathing or chest indrawing. Bacterial pneumonia requires antibiotic. Avoid antibiotic for non-pneumonia viral ARI to combat AMR
Supportive care for non-severe ARI (home)^[1]
Increase fluids, continue feeding/breastfeeding, paracetamol for fever, saline drops + suction for nasal blockage, avoid cough/cold combinations in <6 years
Pre-referral antibiotic and urgent transfer for PSBI^[1]
Young infant <2 months with PSBI signs: IM gentamicin 5 mg/kg + oral amoxicillin 25 mg/kg BD as first dose; arrange immediate referral; if referral truly impossible, community management with daily ANM follow-up × 7 days
Inpatient management of severe pneumonia^[1]
Oxygen for SpO2 <90%, IV antibiotic, fluid management (avoid over-hydration; SIADH), nutrition (NG if unable to feed), monitor for empyema and treatment failure
Oxygen therapy^[1]
Targeted oxygen for SpO2 <90% via nasal cannula 1–2 L/min; high-flow nasal oxygen (1–2 L/kg/min) for moderate-severe distress; CPAP/HFNC pre-PICU

First-line drug therapy

Drug	Class	Adult	Paediatric	Notes
Amoxicillin (oral)^[1]	Aminopenicillin	Not applicable — paediatric guideline	Pneumonia non-severe: 50 mg/kg/day in 2 divided doses × 5 days. PSBI pre-referral: 25 mg/kg single dose	First-line oral antibiotic for pneumonia in children ≥2 months; high-dose vs amoxicillin-resistance regions; PSBI uses lower stat dose with gentamicin
Co-amoxiclav (amoxicillin-clavulanate)^[1]	Aminopenicillin + beta-lactamase inhibitor	Not applicable — paediatric guideline	45–80 mg/kg/day amoxicillin component in 2 divided doses × 5–10 days	Severe pneumonia, treatment failure, suspected H influenzae or atypical; oral or IV; switch from IV when stable
Ampicillin (IV) + gentamicin^[1]	Aminopenicillin + aminoglycoside	Not applicable — paediatric guideline	Ampicillin 50 mg/kg every 6 h IV; gentamicin 7.5 mg/kg/day IV (neonates per local protocol)	First-line inpatient severe pneumonia or sepsis; switch oral after improvement; gentamicin levels and renal function in prolonged courses
Ceftriaxone (IV)^[1]	Third-generation cephalosporin	Not applicable — paediatric guideline	50–80 mg/kg/day IV once daily (max 2 g)	Severe pneumonia, suspected meningitis, treatment failure; covers H influenzae and pneumococcus
Salbutamol (nebulised) for wheeze^[1]	Short-acting beta-2 agonist	Not applicable — paediatric guideline	0.15 mg/kg/dose (min 2.5 mg, max 5 mg) every 20 min × 3 then every 4–6 h	For wheeze with respiratory distress; reassess after each dose; consider pneumonia plus reactive airways

Amoxicillin (oral)^[1]

Aminopenicillin

Adult: Not applicable — paediatric guideline
Paediatric: Pneumonia non-severe: 50 mg/kg/day in 2 divided doses × 5 days. PSBI pre-referral: 25 mg/kg single dose

First-line oral antibiotic for pneumonia in children ≥2 months; high-dose vs amoxicillin-resistance regions; PSBI uses lower stat dose with gentamicin

Co-amoxiclav (amoxicillin-clavulanate)^[1]

Aminopenicillin + beta-lactamase inhibitor

Adult: Not applicable — paediatric guideline
Paediatric: 45–80 mg/kg/day amoxicillin component in 2 divided doses × 5–10 days

Severe pneumonia, treatment failure, suspected H influenzae or atypical; oral or IV; switch from IV when stable

Ampicillin (IV) + gentamicin^[1]

Aminopenicillin + aminoglycoside

Adult: Not applicable — paediatric guideline
Paediatric: Ampicillin 50 mg/kg every 6 h IV; gentamicin 7.5 mg/kg/day IV (neonates per local protocol)

First-line inpatient severe pneumonia or sepsis; switch oral after improvement; gentamicin levels and renal function in prolonged courses

Ceftriaxone (IV)^[1]

Third-generation cephalosporin

Adult: Not applicable — paediatric guideline
Paediatric: 50–80 mg/kg/day IV once daily (max 2 g)

Severe pneumonia, suspected meningitis, treatment failure; covers H influenzae and pneumococcus

Salbutamol (nebulised) for wheeze^[1]

Short-acting beta-2 agonist

Adult: Not applicable — paediatric guideline
Paediatric: 0.15 mg/kg/dose (min 2.5 mg, max 5 mg) every 20 min × 3 then every 4–6 h

For wheeze with respiratory distress; reassess after each dose; consider pneumonia plus reactive airways

Safety-net

Return same-day if breathing becomes faster or harder, child becomes drowsy or floppy, cannot drink, develops fever above 39°C lasting >3 days, or fewer than half normal wet nappies^[1]
Pneumococcal and Hib vaccinations dramatically reduce pneumonia risk — bring vaccinations up to date per national schedule (UIP)^[1]
Avoid cough and cold combination medicines in children <6 years — they do not help and can cause harm; saline drops and bulb suction are safer^[1]

Referral criteria

Possible serious bacterial infection in young infant (<2 months)Pre-referral antibiotic and immediate referral to higher facility; JSSK transport scheme^[1]
Severe pneumonia, hypoxia, or failure of first-line outpatient antibiotic at 48 hPaediatric admission^[1]
Suspected complications (empyema, abscess, meningitis, sepsis)Tertiary paediatric centre^[1]
Recurrent pneumonia (>1 episode/year), failure to thrive, or chronic coughPaediatric respiratory medicine — consider immunodeficiency, foreign body, anatomical lesion, TB, asthma^[1]

Clinical summary

Triage and management of acute respiratory infection in children <5 years using IMNCI thresholds; antibiotic stewardship for viral vs bacterial.

References

1.MoHFW Standard Treatment Guidelines — Respiratory Infections in Children (2021); IMCI/IMNCI; WHO Pocket Book of Hospital Care for Children (2021)

Drug

Class

Adult

Paediatric

Notes

Amoxicillin (oral)^[1]

Aminopenicillin